Professor Who Paused Puberty Blocker Trial Recused Over Gender-Critical Views

Is George's recusal from the trial proper safety protocol or unlawful discrimination against protected beliefs?

Published 2 days ago

Professor Who Paused Puberty Blocker Trial Recused Over Gender-Critical Views

story

Above: The entrance of the NHS Tavistock center, where the Tavistock Clinic hosted the Gender Identity Development Service (GIDS) for children until March 28, 2024. Image credit: Henry Nicholls/AFP/Getty Images

The Spin

Pro-establishment narrative

In trials involving minors, regulatory agencies must maintain rigorous and, critically, impartial oversight to ensure their safety. As such, when concerns arise about the potential for personal biases to influence this work, the MHRA is required to act quickly to protect the integrity of the trial and the safety of its participants, which it has done in this instance.

GOV.UK

Establishment-critical narrative

The MHRA's removal of a chief medical officer for stating biological facts about sex is undoubtedly an unlawful act of discrimination that undermines medical regulation. Gender-critical beliefs are protected, reasonable and essential for healthcare professionals, yet institutions continue to punish this clarity while embracing biased ideology.

Maya Forstater on X Sex Matters